2929 — Pharma Foods International Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSuper Stock

Annual income statement for Pharma Foods International, fiscal year end - July 31st, JPY millions except per share, conversion factor applied.

	2022 July 31st	2023 July 31st	2024 July 31st	2025 July 31st	2026 July 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Preliminary
Revenue
Total Revenue	60,185	68,572	62,147	65,260	63,223
Cost of Revenue
Gross Profit	48,108	55,279	48,752	52,584	50,693
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	59,023	65,004	57,259	63,011	60,591
Operating Profit	1,162	3,568	4,888	2,249	2,632
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,423	3,542	5,034	2,434	2,327
Provision for Income Taxes
Net Income After Taxes	-374	3,080	3,206	368	1,989
Minority Interest
Net Income Before Extraordinary Items
Net Income	-374	3,080	3,206	368	1,989
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-374	3,081	3,205	368	1,988
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-14.7	111	121	17.3	73.1
Dividends per Share